Canadian Blood Services and the CITF’s collaborative nine-province SARS-CoV-2 seroprevalence study for October thru November suggests that 1.5 per cent of healthy Canadians had been exposed to SARS-CoV-2. The highest levels were recorded in Western Canada but mass national vaccination remains only route to achieving herd immunity.
COVID-19 poses a serious health threat to people experiencing homelessness. Homelessness puts people at high risk during the COVID-19 pandemic, as shelters are an ideal environment for the transmission of SARS-CoV-2, the virus that causes COVID-19. More than 235,000 Canadians experience homelessness every year. Recruitment starts soon for the COVENANT study, which will provide [...]
Canada’s COVID-19 Immunity Task Force (CITF) is supporting a BC Children’s Hospital-led research project that aims to better grasp the role that children and young adults have played in the development of the COVID-19 pandemic in British Columbia (BC).
Two studies will help determine whether health care workers in Canada are at higher risk of contracting SARS-CoV-2
Preliminary, non-peer reviewed results suggest that in phase 1 of a study on healthcare workers led by Dr. Nicola Cherry at the University of Alberta, rates of infection were higher in physicians than in other HCWs and higher in Quebec physicians than among physicians in Alberta.
Canada’s COVID-19 Immunity Task Force (CITF) is supporting a new study to identify how many Canadians have been previously infected with SARS-CoV-2, the virus that causes COVID-19. The project, conducted by Statistics Canada, will be the first to use a nationally representative sample to reflect COVID-19 seroprevalence right across Canada at national, provincial, and [...]
Canada’s COVID-19 Immunity Task Force funds national study looking at seroprevalence of COVID-19 antibodies among high-risk populations
The Government of Canada is investing $1.9 million through Canada’s COVID-19 Immunity Task Force (CITF) to fund a Canadian Partnership for Tomorrow’s Health (CanPath) study looking at COVID-19 seroprevalence across Canada, with a particular focus on certain populations that are at higher risk of infection. CanPath is a national population health research platform that follows the health of 330,000 Canadians (or [...]
Study underway in Montreal to estimate how many children and teens have been infected with SARS-CoV-2
Today, Canada’s COVID-19 Immunity Task Force (CITF) announces its support for a research project that will estimate how many children and teens in Montreal have been infected with SARS-CoV-2, the virus that causes COVID-19. This $720,000 investment will allow us to better understand how much virus transmission has occurred to children and teens, and [...]